One major factor in my MFI Index outperforming the benchmark in 2018 was mergers and acquisitions. Of the 50 stocks, 6 were taken over (ABCD, ESRX, BIVV, PCOA, SYNT and CPLA). And now on day 2 of new trading year, we have BMY taking over CELG. (Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever).
So we're off to a roaring start. One first day, MFI Index was up 1.84%. And with a 30+% premium for CELG, today should good as well (although semi stocks like AMAT will be taking hit on AAPL news).
Sadly, I don't own CELG. It was in my 11/15/17 MFI Select portfolio, but was sold in November 2018. Ironically, it was actually a "stinker" down 30.8%.
But, there may be a rising tide effect and I do own AMGN and GILD.
Posts
No comments:
Post a Comment